CDK4, a new metabolic sensor that antagonizes AMPK

L. Fajas, I. C. Lopez-Mejia

Open source

DOI
10.1080/23723556.2017.1409862
Published
2018-05-16
Container
Molecular & Cellular Oncology
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/23723556.2017.1409862,
  title = {CDK4, a new metabolic sensor that antagonizes AMPK},
  author = {L. Fajas and I. C. Lopez-Mejia},
  year = {2018},
  journal = {Molecular \& Cellular Oncology},
  doi = {10.1080/23723556.2017.1409862},
  url = {https://doi.org/10.1080/23723556.2017.1409862}
}

RIS

TY  - JOUR
TI  - CDK4, a new metabolic sensor that antagonizes AMPK
AU  - L. Fajas
AU  - I. C. Lopez-Mejia
PY  - 2018
JO  - Molecular & Cellular Oncology
DO  - 10.1080/23723556.2017.1409862
UR  - https://doi.org/10.1080/23723556.2017.1409862
ER  - 

APA

Fajas, L., & Lopez-Mejia, I. C. (2018). CDK4, a new metabolic sensor that antagonizes AMPK. Molecular & Cellular Oncology. https://doi.org/10.1080/23723556.2017.1409862

Source records